Izvestiya of Saratov University.

Economics. Management. Law

ISSN 1994-2540 (Print)
ISSN 2542-1956 (Online)


For citation:

Buynitskaya E. S. Managerial Aspect in Activity of Pharmaceutical Companies. Journal Izvestiya of Saratov University. Economics. Management. Law, 2015, vol. 15, iss. 3, pp. 303-309. DOI: 10.18500/1994-2540-2015-15-3-303-309

This is an open access article distributed under the terms of Creative Commons Attribution 4.0 International License (CC-BY 4.0).
Full text PDF(Ru):
Language: 
Russian
Heading: 
Article type: 
Article
UDC: 
658.14

Managerial Aspect in Activity of Pharmaceutical Companies

Autors: 
Buynitskaya Ekaterina Sergeevna, St. Petersburg State University of Economics UNECON
Abstract: 

Introduction. The article explains the use of the project approach in the management of innovative activity of pharmaceutical companies and determining the cost-effectiveness of investments in innovation activities of pharmaceutical companies. Theoretical analysis. The activity of pharmaceutical companies is increasingly taking the form of projects. This is primarily due to the necessity of standardization the most important aspects of corporate management activities of pharmaceutical companies. In the conditions of high competitive environment in order to ensure the survival of the pharmaceutical enterprises in these conditions, it is necessary to realize the innovation activity under condition of using the system of innovation project management. The necessity of creating the system of innovation project management at pharmaceutical manufactory is specify of development of pharmaceutical market, which needs in fast response. That’s why in order to achieve the effectiveness of using resources, observance of time of implementation of management decisions necessary to ensure optimum interaction processes (or all activities) under the conditions of each project. According to the author, in the project management system, it is expedient to introduce evaluation of innovative projects based on the concept of real options. Results. Revealed the value of real options approach with a high degree of uncertainty in terms of functioning of the company and the possibility of managerial influence on it. It is appeared the possibility and right to change strategy.

Reference: 
  1. Luchkin V. Azbuka upravlenija proektami vnedrenija innovacij [The ABC project management innovation]. Den’gi i tehnologii [Money and technologies], 2006, no. 5, pp. 34–37.
  2. Upravlenie proektom: Osnovy proektnogo upravlenija [Manage the project. Fundamentals of project management. Textbook. 3rd ed. Ed. by M. L. Razu.]. Moscow, KNORUS Publ., 2010. 760 p.
  3. GOST R ISO 21500 – 2014 «Rukovodstvo po proektnomu menedzhmentu» (GOST R ISO 21500 – 2014 «Guidance on project management»). Available at: http://protect.gost.ru/document.aspx?control=7&baseC=6&page=42&month=3&year=2015&search=&id=198457 (accessed 22 April 2015).
  4. Onis’ko O. V. Dolgaja doroga k GMP [The long road to GMP]. Mister Blister, 2006, no. 12, pp. 9–10.
  5. Mazur I. I., Shapiro V. D. (ed.). Upravlenie proektami [Project Management. 6th ed., ster.]. Moscow, Omega-L Publ., 2010. 960 p.
  6. Limitovskij M. A. Investicionnye proekty i real’nye opciony na razvivajushhihsja rynkah [Investment projects and real options in emerging markets. 5th ed., reslave. and additional]. Moscow, Jurajt Publ., 2014. 486 p.
  7. Brealey R., Myers S., Allen F. Principles of Corporate Finance. New York, McGraw-Hill Education, 2014. 976 p.
  8. Copeland T., Koller T., Murrin J. Valuation: Measuring and Managing the Value of Companies. 5th ed. New York, John Wiley & Sons, 2010. 840 p.
  9. Rogova E. M., Jarygin A. I., Sirik E. S. Venchurnye investicii v biofarmacevticheskie kompanii: podhod k ocenke jeffektivnosti proektov [Venture capital investments in pharmaceutical companies: an approach to evaluating the effectiveness of projects]. Innovacii [Innovations], 2012, no. 9 (167), pp. 39–47.
Received: 
30.08.2015
Accepted: 
30.09.2015